Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Opiranserin as an Adjunct for Pain Control After Open Gastrectomy
KCT0012115Phase 4Not yet recruiting
- Sponsor
- Yonsei University Health System
- Start
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of opiranserin in gastric cancer (GC), sponsored by Yonsei University Health System. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
opiranserin
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on KCT0012115.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0012115.